by Sue Robbins | Aug 12, 2020 | Miscellaneous
Despite spending around one-third of our lives in the land of nod, sleep still holds many mysteries. Scientists are chipping away at the details, but the wonder of slumber is much more complex than it appears. In this Special Feature, we dispel some common myths....
by Sue Robbins | Aug 4, 2020 | Miscellaneous
When we start to lift weights, our muscles do not strengthen and change at first, but our nervous systems do, according to a fascinating new study in animals of the cellular effects of resistance training. The study, which involved monkeys performing the equivalent of...
by Sue Robbins | Aug 3, 2020 | Miscellaneous
A new blood test demonstrated remarkable promise in discriminating between persons with and without Alzheimer’s disease and in persons at known genetic risk may be able to detect the disease as early as 20 years before the onset of cognitive...
by Sue Robbins | Jul 30, 2020 | Migraine
Phase 3 ADVANCE trial evaluating atogepant meets primary endpoint of statistically significant reduction from baseline in mean monthly migraine days, compared to placebo, for all doses evaluated across a 12-week treatment period – Trial also...
by Sue Robbins | Jul 28, 2020 | Migraine
In patients with episodic migraine, erenumab provided sustained efficacy for the condition over the course of 1 year, according to new results from a study to evaluate the efficacy and safety of erenumab in migraine prevention (STRIVE), published in Neurology....
